Skip to content

Effects of butorphanol on early postoperative cognitive function and inflammation in elderly patients

Effects of butorphanol on early postoperative cognitive function and inflammation in elderly patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070805
Enrollment
Unknown
Registered
2023-04-24
Start date
2023-04-25
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

Butorphanol group(B):Butorphanol 40µg/kg was administered during induction of anesthesia
Sufentanil group (S ):Sufentanil 0.4µg/kg was administered during induction of anesthesia

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.ASA I-III 2.Preoperative MoCA score >= 26 3.Preoperative MMSE score >23 4. Patients undergoing surgery under general anesthesia (including general surgery, orthopedics, urology, gynecology) 5.The operation time is expected to be more than two hours 6. Patients aged =65 years

Exclusion criteria

Exclusion criteria: 1. Suffering from neurological and mental diseases and neurodegenerative diseases 2. Liver and kidney dysfunction (ChildePugh grade C, serum creatinine >125 µmol/L) 3. Recent use of sedative hypnotics, analgesics, antidepressants, glucocorticoids or other immunosuppressive agents 4. History of drug and alcohol abuse 5. Severe visual and hearing impairment that affects communication 6. BMI>30kg/m2 7. Contraindications of butorphanol application 8.The patient could not understand and cooperate to complete the MoCA and MMSE evaluation before operation

Design outcomes

Primary

MeasureTime frame
Postoperative cognitive dysfunction;

Secondary

MeasureTime frame
inflammatory factor;

Countries

China

Contacts

Public ContactSun Defeng

The First Affiliated Hospital of Dalian Medical University

sdf-yl@163.com+86 18098876191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026